1 / 7

Molecular Diagnostics Market by Product & Services, Technique, End Users and Global Region - Analysis & Forecast 2019-20

Sequencing technology segment is forecasted to witness 14.7% CAGR over the forecast period. Sequencing is being widely used in molecular diagnosis of paediatric diseases such as Duchenne muscular dystrophy and monogenic diabetes. Sanger sequencing is the choice of method for mutation screening, however next generation sequencing (NGS) is rapidly being recognized as most efficient technology for detection and screening of genetic variations.

Download Presentation

Molecular Diagnostics Market by Product & Services, Technique, End Users and Global Region - Analysis & Forecast 2019-20

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Market Industry Reports Advanced Wound Care Market by Product Global Analysis & Forecast 2019-2030

  2. Molecular Diagnostics Market by Product & Services (Reagents & Kits, Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users (Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and Region - Global Analysis & Forecast 2019-2030 Molecular Diagnostics Market Market Industry Reports (MIR) has published a new report titled “Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report the global molecular diagnostics market was valued at over US$ 6 Bn in 2017 and is expected to grow at a double digit in the forecasted period. The growth of this market can be attributed to the factors such as, growing number of infectious diseases, hospital acquired infections and various other diseases. Molecular diagnostics is a vital tool for the cost-effective, accurate, rapid, delivery of effective and safe therapy for many diseases. Increasing cases of hospital acquired infections and (add more drivers) have led to the growing need for molecular diagnostic in hospitals facilities. According to Centers for Disease Control (CDC) in 2017, Hospitals Acquired Infections (HAI) accounted for almost 1.7 million cases with 99,000 deaths every year in the U.S.

  3. Molecular Diagnostics Market by Product & Services (Reagents & Kits, Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users (Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and Region - Global Analysis & Forecast 2019-2030 Increasing funding by governments and various organizations for research and clinical studies in the molecular diagnosis space are anticipated to boost the market growth. These initiatives by the government play an important role in the practice of new product development. For instance, Accelerate Diagnostics received a funding of USD 19.45 million by different organizations, including the Oracle Institutional Partners, Schuler Family Foundation, Oracle Partners, & various others, for development and sale of IVD tests and tools. Moreover, in 2015, Merck’s venture capital arm funded AdvanDx with almost USD 12 million for R&D of pathogen screening for key HAI. Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report,  Molecular Diagnostics Market by Product & Services (Reagents & Kits, Instruments, Services) Technique (PCR, Sequencing, Electrophoresis), End Users (Diagnostic & Research laboratories, Pharmaceutical & Bio Technique Companies) and Region - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/10/molecular-diagnostics-market

  4. Molecular Diagnostics Market by Product & Services, Technique, End Users and Global Region - Analysis & Forecast 2019-2030 Molecular Diagnostics Market, By Technology Sequencing technology segment is forecasted to witness 14.7% CAGR over the forecast period. Sequencing is being widely used in molecular diagnosis of paediatric diseases such as Duchenne muscular dystrophy and monogenic diabetes. Sanger sequencing is the choice of method for mutation screening, however next generation sequencing (NGS) is rapidly being recognized as most efficient technology for detection and screening of genetic variations.  Targeted NGS offers better quality and simplified dataset analysis that will spur its demand in near future. Molecular Diagnostics Market, By Region Germany molecular diagnostics market accounted for USD 426.1 million is 2017. Germany currently dominates the European molecular diagnostic industry and scenario is likely to remain so in near future. Increasing incidences of lifestyle and infectious diseases coupled with favourable demographic trends such as aging population will drive the industry growth. Robust research and development in molecular diagnostic field and high awareness regarding the benefits of early diagnosis will expand the molecular diagnostics market growth in Germany.

  5. Molecular Diagnostics Market by Product & Services, Technique, End Users and Global Region - Analysis & Forecast 2019-2030 Companies are working on expanding their product portfolio to get a hold on the market Vaarious key players are adopting strategies such as Mergers and Acquisitions (M&A) to increase their market share. For instance, Hologic acquired Gen-Probe, to expand its  product portfolio with focus on various types of cancer’s diagnostics. Moreover, Cepheid launched GeneXpert Omni in 2015, which is the most portable molecular diagnostics system in the world. Some of the major players in the molecular diagnostics market include Bio-Rad Laboratories, Inc.; Bayer AG; Siemens Healthcare GmbH; Abbott; Alere, Inc.; Danaher; Dickinson and Company;  Dako; Hologic, Inc. (Gen probe); Novartis AG;  Sysmex Corporation; Qiagen N.V.; Johnson & Johnson; Becton, Roche Diagnostics; bioMerieux SA; and Cepheid among others. GET FREE SAMPLE- https://www.marketindustryreports.com/pdf/10 Visit : https://www.marketindustryreports.com/1/advanced-wound-care-market

  6. CONTACT US 502, Sai Radhe, Kennedy Road, Behind Hotel Sheraton Grand, Near Pune Station, Pune 411 001,Maharashtra, India Email: sales@marketindustryreports.com Phone: + 91 8956 767 535 Connect with us : Visit : https://www.marketindustryreports.com/contact-us

  7. About Market Industry Reports Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. Visit : https://www.marketindustryreports.com/13/wearable-injectors-market

More Related